Ambrx Biopharma (AMAM) Competitor Comparison
We are evaluating the key criteria listed to compare Ambrx Biopharma (AMAM) against its competitors in the Biotechnology industry.
Market Capitalization
89 / 368Gross Profits
104 / 278Total Revenue
207 / 300EBITDA
152 / 337Free Cashflow
177 / 352Quick Ratio
60 / 357Earnings per Share
29 / 359Dividend yield
0 / 6Total Cash
142 / 358Performance 3 years
60 / 368Performance 5 years
98 / 368Performance 10 years
80 / 368Linearity 3 years
326 / 368Linearity 5 years
324 / 368Linearity 10 years
321 / 368Total Rank
287 / 368Dividend Rank
347 / 368Valuation Rank
318 / 368Piotroski Rank
362 / 368Muliplier Rank
265 / 368Dividend Rank - AMAM ranking 347 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.